BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23214010)

  • 1. [Maastricht consensus-4 (2011). Main provisions and comments].
    Tsimmerman IaS
    Klin Med (Mosk); 2012; 90(9):28-34. PubMed ID: 23214010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori infection in pediatric population: epidemiology, pathophysiology, and therapy.
    Wallis-Crespo MC; Crespo A
    Fetal Pediatr Pathol; 2004 Jan; 23(1):11-28. PubMed ID: 15371120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The evoluation of the strategy and tactics of treatment of Helicobacter pylori-dependent diseases].
    Tsimmerman IaS
    Klin Med (Mosk); 2007; 85(8):9-14. PubMed ID: 17926482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Eradication efficiency and Helicobacter pylori resistance to antibiotics in anticipation of IV TH Maastricht consensus issues publication. Editorial].
    Lazebnik LB; Bordin DS; Mikheeva OM; Belousova NL
    Eksp Klin Gastroenterol; 2011; (8):3-7. PubMed ID: 22629748
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gastroduodenal diseases and Helicobacter pylori infection: overview].
    Tsimmerman IaS
    Klin Med (Mosk); 2009; 87(5):9-15. PubMed ID: 19565820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [European consensus on Helicobacter pylori infection in children].
    Casswall T
    Lakartidningen; 2001 Mar; 98(11):1240-2. PubMed ID: 11293129
    [No Abstract]   [Full Text] [Related]  

  • 7. National consensus on the management of Helicobacter pylori infection 2003.
    Indonesian Gastroenerology Association and Indonesian Helicobacter pylori Study Group
    Acta Med Indones; 2004; 36(4):239-41. PubMed ID: 15673954
    [No Abstract]   [Full Text] [Related]  

  • 8. New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
    Gasbarrini G; Malfertheiner P; Deltenre M; Mégraud F; O'Morain C; Pajares-García J; Quina M; Bianchi Porro G; Gasbarrini A; Franceschi F; Armuzzi A; Cammarota G; Anti M; Pretolani S
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S244-7. PubMed ID: 10077746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Report from an international consensus conference in Maastricht. Management and treatment of Helicobacter pylori infection].
    Sjölund K; Ljungh A
    Lakartidningen; 2001 Mar; 98(11):1235-8. PubMed ID: 11293128
    [No Abstract]   [Full Text] [Related]  

  • 10. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
    Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B
    Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A consensus meeting about HP-related diseases, again?
    Deltenre M; Geboes K
    Acta Gastroenterol Belg; 1998; 61(3):298. PubMed ID: 9795457
    [No Abstract]   [Full Text] [Related]  

  • 12. "Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy.
    Caselli M; Zullo A; Maconi G; Parente F; Alvisi V; Casetti T; Sorrentino D; Gasbarrini G;
    Dig Liver Dis; 2007 Aug; 39(8):782-9. PubMed ID: 17606419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children.
    Koletzko S; Jones NL; Goodman KJ; Gold B; Rowland M; Cadranel S; Chong S; Colletti RB; Casswall T; Elitsur Y; Guarner J; Kalach N; Madrazo A; Megraud F; Oderda G;
    J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):230-43. PubMed ID: 21558964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Helicobacter pylori. Which patients should be examined and treated?].
    Lauritsen K; Wilson BV
    Nord Med; 1997 Jun; 112(6):192-4. PubMed ID: 9273512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ulcer disease: challenging problems of etiology, pathogenesis, differential treatment].
    Tsimmerman IaS
    Klin Med (Mosk); 2012; 90(8):11-8. PubMed ID: 23101253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
    Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
    Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the management of Helicobacter pylori infection in general practice.
    Tosetti C
    Helicobacter; 2006 Jun; 11(3):208-10. PubMed ID: 16684269
    [No Abstract]   [Full Text] [Related]  

  • 19. Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole.
    Nijevitch AA; Farztdinov KM; Sataev VU; Khasanov RSh ; Katayev VA; Khusnutdinov SM; Akhunov ED; Kazykhanov NS
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1243-50. PubMed ID: 11129216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori infection in pediatrics.
    Veres G; Pehlivanoglu E
    Helicobacter; 2007 Oct; 12 Suppl 1():38-44. PubMed ID: 17727459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.